薯蓣皂苷元含药血清对IL-17和TNF-α诱导大鼠滑膜细胞株RSC-364 NF-κB p65、AP-1的影响  

Effects of medicated serum with diosgenin on NF-κB p65 and AP-1 expression in rat synovial cell strain RSC-364 induced by IL-17 and TNF-α

作　　者：赵婷[1] 郭亚春[1] 高亚贤[1] 宋鸿儒[1] 

机构地区：[1]承德医学院,承德067000

出　　处：《中华中医药杂志》2013年第9期2794-2797,共4页China Journal of Traditional Chinese Medicine and Pharmacy

基　　金：国家自然基金面上项目(No.30873420);河北省教育厅重大项目(No.ZH200806)~~

摘　　要：目的:通过观察薯蓣皂苷元含药血清对白介素-17(IL-17)和肿瘤坏死因子-α(TNF-α)联合诱导的大鼠滑膜细胞株RSC-364核转录因子-κB(NF-κB)p65及活化蛋白-1(AP-1)表达的影响,探讨薯蓣皂苷元抑制类风湿关节炎(RA)血管新生可能的信号转导通路作用机制。方法:实验分为空白对照组、RA细胞模型组、薯蓣皂苷元含药血清组与雷公藤含药血清组,应用TransAM^(TM) NF-κB p65活性检测试剂盒检测NF-κB p65的DNA结合活性,应用EMSA方法检测AP-1的DNA结合活性。结果:与RA细胞模型组相比,薯蓣皂苷元含药血清组的NF-κB p65DNA结合活性显著降低(P<0.01),薯蓣皂苷元含药血清组AP-1的DNA结合活性降低(P<0.01)。结论:薯蓣皂苷元含药血清可以抑制IL-17和TNF-α联合诱导的大鼠滑膜细胞株RSC-364细胞模型NF-κB p65、AP-1的DNA结合活性,从而起到抑制RA血管新生的作用。Objective： To observe the effects of medicated serum with diosgenin on NF＊rB p65 and AP-1 expression in rat synovial cell strain RSC-364 induced by IL-17 and TNF-a, and investigate the underlying mechanism about signal lransduction pathways of diosgenin on antiangiogenesis in treating rheumatoid arthritis＇ （RA）. Methods： The cells were divided into 4 groups： blank control group, RA model group, diosgenin medicated serum group and tripterygium medicated serum group. The NF-xB p65 expression in rat synovial cell strain RSC-364 in each group was detected by TransAMTM, the AP-1 expression in rat synovial cell strain RSC-364 in each group was detected by EMSA. Results： The NF-xB p65 activity in diosgenin medicated serum group was remarkably lower than that RA model group （P〈0.01）. The AP-1 DNA-binding activity in nuclear extract of diosgenin medicated serum group were remarkably lower than that RA model group （P〈0.01）. Conclusion： Diosgenin could remarkably lower NF- xB p65 and AP-1 DNA-binding activity in rat synovial cell strain RSC-364 induced by IL-17 and TNF-a, thereby to restrain angiogenesis of rheumatoid arthritis.

关 键 词：薯蓣皂苷元 类风湿关节炎 核转录因子-κB 活化蛋白-1 

分 类 号：R259[医药卫生—中西医结合]